Add Company
Join Now

Bridget Walton Email

VP, Global Regulatory Affairs . MindMed

New York, NY

Location

b******@mindmed.co

Primary Email

How to contact Bridget Walton

Join and see Bridget's contact info for free!

Email

Current Roles

MindMed

Employees:
109
Revenue:
$16.9M
About
MindMed is a psychedelic medicine biotech company that discovers, develops and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC. The MindMed executive team brings extensive biopharmaceutical experience to the company's groundbreaking approach to developing the next-generation of psychedelic inspired medicines and therapies. MindMed trades on the Canadian exchange NEO under the symbol MMED. MindMed is also traded in the United States under the symbol MMEDF and in Germany under the symbol MMQ. For more information: www.mindmed.co
MindMed Address
One World Trade Center
New York, NY
United States
MindMed Email

Past Companies

MindMedVice President, Global Regulatory Affairs
Sunovion Pharmaceuticals Inc.Executive Director, Global Regulatory Affairs
Sunovion Pharmaceuticals Inc.Senior Director, Global Regulatory Affairs
www.growjo.com

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.